EventsMCS.HEADER.NEWSPodcastsVideosTraining & EducationProcedure GuidesWebinarsSurgical Valve TherapiesSurgical Treatment for CAD
DISCLAIMER: The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing. If not approved, please exit this page.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Recent happenings and trends in mitral valve repair (Segment 4)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Recent happenings and trends in mitral valve repair (Segment 3)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Recent happenings and trends in mitral valve repair (Segment 2)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Recent happenings and trends in mitral valve repair (Segment 1)
Published on
In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with three-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG versus medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with three-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG versus medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc from the University of British Columbia, and Dr. Tom Nguyen from UCSF.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc from the University of British Columbia, and Dr. Tom Nguyen from UCSF.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc from the University of British Columbia, and Dr. Tom Nguyen from UCSF.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc from the University of British Columbia, and Dr. Tom Nguyen from UCSF.
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
International OPCAB Masterclass 6th Edition 2023 | 13:00 - 19:00 CET
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
The evolution of ECMO with Dr. Robert Bartlett (Segment 1)
Published on
Lifesaving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO" Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving lifesaving ECMO changes today. Dr. Bartlett also shares his perspective on th...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Current practices and future state of coronary surgery (Segment 2)
Published on
Hear an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the rol...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
Current practices and future state of coronary surgery (Segment 1)
Published on
Hear an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the rol...
The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.
